The pharmaceutical and biotechnology sectors, which endured a protracted period of aggressive workforce contraction beginning in 2022, are beginning to…
Read More
Alphabet and Meta now spend nearly as much on R&D as pharma’s 10 largest drugmakers
The landscape of global research and development is undergoing a tectonic shift as the financial muscle of Big Tech begins…
Read More
Metabolic stability: The defining challenge for multifunctional peptides
The pharmaceutical landscape is currently undergoing a structural metamorphosis driven by the meteoric rise of peptide therapeutics. Once relegated to…
Read More
Before its recent Phase 3 LSD win, Definium modeled up to $70,000 a year for a therapy that could fill a clinical shift
The landscape of psychiatric medicine is undergoing a profound transformation as pharmaceutical companies transition from chronic, daily-dosing regimens to high-intensity,…
Read More
AAPS PharmSci 360 Offers Fresh Insights for Industry Scientists
The pharmaceutical industry stands at a critical juncture where the integration of advanced computational modeling, novel biological delivery systems, and…
Read More
FDA logs more than 1,700 adverse event reports involving compounded semaglutide and tirzepatide
The regulatory landscape surrounding weight-loss medications has reached a critical juncture as the Food and Drug Administration (FDA) reports a…
Read More
FDA greenlights ViiV’s Tivicay PD for HIV-positive newborns in first month of life
The U.S. Food and Drug Administration (FDA) has granted a significant regulatory expansion for ViiV Healthcare’s Tivicay PD (dolutegravir), a…
Read More
Tufts model estimates 82x ROI and up to $21 million in value from Medable AI agent
The integration of artificial intelligence into clinical research has reached a critical inflection point, moving beyond experimental pilot programs to…
Read More
Pharma tariffs reach smaller drugmakers as industry warns of R&D pressure
The landscape for pharmaceutical manufacturing in the United States underwent a significant shift on September 29, 2026, as the scope…
Read More
As the dream of the autonomous clinical trial dawns, agent supervision is today’s human job
The landscape of modern drug development is currently undergoing a radical structural transformation driven by the collision of two opposing…
Read More
